Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 2/2017

01-04-2017 | Current Opinion

Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors

Authors: Divya Sharma, Thomas Lee, Adam J. Friedman, Kelley Pagliai Redbord

Published in: American Journal of Clinical Dermatology | Issue 2/2017

Login to get access

Abstract

Survivors of pediatric cancer are at increased risk of developing secondary malignancies, with non-melanoma skin cancer being the most common. These patients are also at increased risk of melanoma. Currently, guidelines provided by the National Cancer Institute and Children’s Oncology Group emphasize the importance of annual clinical examination for skin cancer screening; however, the literature reports that less than one-third of survivors of pediatric cancer have ever had a clinical skin exam by a physician. In this article, we review the risk factors for skin cancer in survivors of pediatric cancer as well as the current evidence and recommendations for their care. We suggest that dermatologists collectively establish guidelines for skin cancer surveillance in survivors of pediatric cancer.
Literature
1.
Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(16):3733–41.CrossRefPubMed
2.
Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95.CrossRefPubMedPubMedCentral
3.
Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer. 2007;121(10):2233–40.CrossRefPubMed
4.
Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24(7):1119–26.CrossRefPubMed
5.
Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011;117(1):316–22.CrossRefPubMedPubMedCentral
6.
Janin A, Murata H, Leboeuf C, Cayuela JM, Gluckman E, Legres L, et al. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood. 2009;113(8):1834–40.CrossRefPubMed
7.
Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105(10):3802–11.CrossRefPubMedPubMedCentral
8.
Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25(2):435–41.CrossRefPubMed
9.
Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2 Pt 1):177–86.CrossRefPubMed
10.
Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49(3):506–9.CrossRefPubMed
11.
Kovach BT, Stasko T. Skin cancer after transplantation. Transpl Rev (Orlando). 2009;23(3):178–89.CrossRef
12.
Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2012;104(16):1240–50.CrossRefPubMedPubMedCentral
13.
Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2013;60(3):461–6.CrossRefPubMed
14.
Ehrhardt MJ, Bhakta N, Liu Q, Yasui Y, Krasin MJ, Mulrooney DA, et al. Absence of basal cell carcinoma in irradiated childhood cancer survivors of black race: a report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomark Prev. 2016;25(9):1356–60.CrossRef
15.
Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res. 2002;157(4):410–8.CrossRefPubMed
16.
Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897–904.CrossRefPubMed
17.
Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154(3):472–7.CrossRefPubMed
18.
Lawless SC, Verma P, Green DM, Mahoney MC. Mortality experiences among 15 + year survivors of childhood and adolescent cancers. Pediatr Blood Cancer. 2007;48(3):333–8.CrossRefPubMed
19.
Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328–38.CrossRefPubMedPubMedCentral
20.
21.
Hansson J, Bergenmar M, Hofer PA, Lundell G, Mansson-Brahme E, Ringborg U, et al. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol. 2007;25(19):2819–24.CrossRefPubMed
22.
Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transpl. 2002;17(Suppl 4):31–6.
23.
24.
Daniel CL, Armstrong GT, Keske RR, Davine JA, McDonald AJ, Sprunck-Harrild KM, et al. Advancing Survivors’ Knowledge (ASK) about skin cancer study: study protocol for a randomized controlled trial. Trials. 2015;16:109.CrossRefPubMedPubMedCentral
25.
26.
27.
28.
Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(4):436–47.CrossRefPubMed
29.
Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Ebell M, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35.
30.
Stapleton JL, Tatum KL, Devine KA, Stephens S, Masterson M, Baig A, et al. Skin cancer surveillance behaviors among childhood cancer survivors. Pediatr Blood Cancer. 2016;63(3):554–7.CrossRefPubMed
31.
Greenberg JN, Zwald FO. Management of skin cancer in solid-organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29(2):231–41, ix.
Metadata
Title
Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors
Authors
Divya Sharma
Thomas Lee
Adam J. Friedman
Kelley Pagliai Redbord
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 2/2017
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0241-1

Other articles of this Issue 2/2017

American Journal of Clinical Dermatology 2/2017 Go to the issue

Therapy in Practice

Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment

Meeting Report

American Academy of Dermatology Annual Meeting

Review Article

The Emerging Zika Virus Threat: A Guide for Dermatologists

Review Article

Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence

Original Research Article

Molecular Diagnostic Techniques for Onychomycosis: Validity and Potential Application

Systematic Review

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review